About
Company Overview
Management Team
Board of Directors
Advisors
Partnering
Careers
CBD
Programs
Overview
Graft versus Host Disease (GVHD)
Acute and Chronic Pain
Additional Preclinical Programs
News
Investors
Investor Overview
Press Releases
Company Information
SEDAR Filings
SEC Filings
Stock Information
Corporate Governance
Contact
About
Company Overview
Management Team
Board of Directors
Advisors
Partnering
Careers
CBD
Programs
Overview
Graft versus Host Disease (GVHD)
Acute and Chronic Pain
Additional Preclinical Programs
News
Investors
Investor Overview
Press Releases
Company Information
SEDAR Filings
SEC Filings
Stock Information
Corporate Governance
Contact
Press Releases
Menu
Overview
Press Releases
Company Information
Stock Information
SEC Filings
Corporate Governance
Recent Press Releases
Kalytera Announces Closing of First Tranche of Private Placement of Common Shares and Common Share Purchase Warrants
September 16, 2019
Kalytera Announces Update to Private Placement
September 11, 2019
Kalytera Announces Interest Payment in Shares
September 9, 2019
Kalytera Reports Second Quarter 2019 Financial Results
August 29, 2019
Kalytera Announces Management-Led Private Placement of Up To $1.5 Million of Common Shares and Common Share Purchase Warrants
August 21, 2019
Kalytera to Conclude Phase 2 Clinical Study and Initiate Phase 3 Study
August 19, 2019
Kalytera Announces Results of Shareholder Meeting Votes
July 29, 2019
View all News and Insights
Browse by Year
2019
2018
2017
2016
2015
